|
1
|
Steiner PE: Carcinoma of the liver in the
United States. Acta Unio Int Contra Cancrum. 13:628–645.
1957.PubMed/NCBI
|
|
2
|
Esposito I and Schirmacher P: Pathological
aspects of cholangiocarcinoma. HPB (Oxford). 10:83–86. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nakeeb A, Pitt HA, Sohn TA, Coleman J,
Abrams RA, Piantadosi S, Hruban RH, Lillemoe KD, Yeo CJ and Cameron
JL: Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and
distal tumors. Ann Surg. 224:463–475. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Klöppel G, Adsay V, Konukiewitz B, Kleeff
J, Schlitter AM and Esposito I: Precancerous lesions of the biliary
tree. Best Pract Res Clin Gastroenterol. 27:285–297. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nuzzo G, Giuliante F, Ardito F, Giovannini
I, Aldrighetti L, Belli G, Bresadola F, Calise F, Valle R Dalla,
D'Amico DF, et al: Improvement in perioperative and long-term
outcome after surgical treatment of hilar cholangiocarcinoma:
Results of an Italian multicenter analysis of 440 patients. Arch
Surg. 147:26–34. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yamamoto M and Ariizumi S: Surgical
outcomes of intrahepatic cholangiocarcinoma. Surg Today.
41:896–902. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rizvi S and Gores GJ: Pathogenesis,
diagnosis, and management of cholangiocarcinoma. Gastroenterology.
145:1215–1229. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Khan SA, Davidson BR, Goldin RD, Heaton N,
Karani J, Pereira SP, Rosenberg WM, Tait P, Taylor-Robinson SD,
Thillainayagam AV, et al: Guidelines for the diagnosis and
treatment of cholangiocarcinoma: An update. Gut. 61:1657–1669.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Parkin DM, Ohshima H, Srivatanakul P and
Vatanasapt V: Cholangiocarcinoma: Epidemiology, mechanisms of
carcinogenesis and prevention. Cancer Epidemiol Biomarkers Prev.
2:537–544. 1993.PubMed/NCBI
|
|
10
|
Chung YE, Kim MJ, Park YN, Choi JY, Pyo
JY, Kim YC, Cho HJ, Kim KA and Choi SY: Varying appearances of
cholangiocarcinoma: Radiologic-pathologic correlation.
Radiographics. 29:683–700. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Welzel TM, Graubard BI, El-Serag HB, Shaib
YH, Hsing AW, Davila JA and McGlynn KA: Risk factors for
intrahepatic and extrahepatic cholangiocarcinoma in the United
States: A population-based case-control study. Clin Gastroenterol
Hepatol. 5:1221–1228. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lazaridis KN and Gores GJ:
Cholangiocarcinoma. Gastroenterology. 128:1655–1667. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Reddy SB and Patel T: Current approaches
to the diagnosis and treatment of cholangiocarcinoma. Curr
Gastroenterol Rep. 8:30–37. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shaib YH, El-Serag HB, Davila JA, Morgan R
and McGlynn KA: Risk factors of intrahepatic cholangiocarcinoma in
the United States: A case-control study. Gastroenterology.
128:620–626. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
El Rassi ZE, Partensky C, Scoazec JY,
Henry L, Lombard-Bohas C and Maddern G: Peripheral
cholangiocarcinoma: Presentation, diagnosis, pathology and
management. Eur J Surg Oncol. 25:375–380. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ito K, Ito H, Allen PJ, Gonen M, Klimstra
D, D'Angelica MI, Fong Y, DeMatteo RP, Brennan MF, Blumgart LH and
Jarnagin WR: Adequate lymph node assessment for extrahepatic bile
duct adenocarcinoma. Ann Surg. 251:675–681. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hong SM, Pawlik TM, Cho H, Aggarwal B,
Goggins M, Hruban RH and Anders RA: Depth of tumor invasion better
predicts prognosis than the current American joint committee on
cancer T classification for distal bile duct carcinoma. Surgery.
146:250–257. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yoshida T, Matsumoto T, Sasaki A, Morii Y,
Shibata K, Ishio T and Kitano S: Lymphatic spread differs according
to tumor location in extrahepatic bile duct cancer.
Hepatogastroenterology. 50:17–20. 2003.PubMed/NCBI
|
|
19
|
Ebata T, Nagino M, Nishio H, Igami T,
Yokoyama Y and Nimura Y: Pancreatic and duodenal invasion in distal
bile duct cancer: Paradox in the tumor classification of the
American joint committee on cancer. World J Surg. 31:2008–2015.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Murakami Y, Uemura K, Hayashidani Y, Sudo
T, Ohge H and Sueda T: Pancreatoduodenectomy for distal
cholangiocarcinoma: Prognostic impact of lymph node metastasis.
World J Surg. 31:337–344. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yoshida T, Matsumoto T, Sasaki A, Morii Y,
Aramaki M and Kitano S: Prognostic factors after
pancreatoduodenectomy with extended lymphadenectomy for distal bile
duct cancer. Arch Surg. 137:69–73. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Murakami Y, Uemura K, Hayashidani Y, Sudo
T, Hashimoto Y, Ohge H and Sueda T: Prognostic significance of
lymph node metastasis and surgical margin status for distal
cholangiocarcinoma. J Surg Oncol. 95:207–212. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Woo SM, Ryu JK, Lee SH, Yoo JW, Park JK,
Kim YT, Jang JY, Kim SW, Kang GH and Yoon YB: Recurrence and
prognostic factors of ampullary carcinoma after radical resection:
Comparison with distal extrahepatic cholangiocarcinoma. Ann Surg
Oncol. 14:3195–3201. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sasaki R, Takeda Y, Funato O, Nitta H,
Kawamura H, Uesugi N, Sugai T, Wakabayashi G and Ohkohchi N:
Significance of ductal margin status in patients undergoing
surgical resection for extrahepatic cholangiocarcinoma. World J
Surg. 31:1788–1796. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kitagawa Y, Nagino M, Kamiya J, Uesaka K,
Sano T, Yamamoto H, Hayakawa N and Nimura Y: Lymph node metastasis
from hilar cholangiocarcinoma: Audit of 110 patients who underwent
regional and paraaortic node dissection. Ann Surg. 233:385–392.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jarnagin WR, Fong Y, DeMatteo RP, Gonen M,
Burke EC, Bodniewicz BSJ, Youssef BAM, Klimstra D and Blumgart LH:
Staging, resectability, and outcome in 225 patients with hilar
cholangiocarcinoma. Ann Surg. 234:507–519. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Soares KC, Kamel I, Cosgrove DP, Herman JM
and Pawlik TM: Hilar cholangiocarcinoma: Diagnosis, treatment
options, and management. Hepatobiliary Surg Nutr. 3:18–34.
2014.PubMed/NCBI
|
|
28
|
Brandi G, Venturi M, Pantaleo MA and
Ercolani G: GICO: Cholangiocarcinoma: Current opinion on clinical
practice diagnostic and therapeutic algorithms: A review of the
literature and a long-standing experience of a referral center. Dig
Liver Dis. 48:231–241. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Serafini FM, Sachs D, Bloomston M, Carey
LC, Karl RC, Murr MM and Rosemurgy AS: Location, not staging, of
cholangiocarcinoma determines the role for adjuvant chemoradiation
therapy. Am Surg. 67:839–844. 2001.PubMed/NCBI
|
|
30
|
Anderson CD, Pinson CW, Berlin J and Chari
RS: Diagnosis and treatment of cholangiocarcinoma. Oncologist.
9:43–57. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pitt HA, Nakeeb A, Abrams RA, Coleman J,
Piantadosi S, Yeo CJ, Lillemore KD and Cameron JL: Perihilar
cholangiocarcinoma. Postoperative radiotherapy does not improve
survival. Ann Surg. 221:788–798. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Farhat MH, Shamseddine AI, Tawil AN,
Berjawi G, Sidani C, Shamseddeen W and Barada KA: Prognostic
factors in patients with advanced cholangiocarcinoma: Role of
surgery, chemotherapy and body mass index. World J Gastroenterol.
14:3224–3230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Razumilava N and Gores GJ:
Cholangiocarcinoma. Lancet. 383:2168–2179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Geynisman DM and Catenacci DV: Toward
personalized treatment of advanced biliary tract cancers. Discov
Med. 14:41–57. 2012.PubMed/NCBI
|
|
35
|
Han W and Lo HW: Landscape of EGFR
signaling network in human cancers: Biology and therapeutic
response in relation to receptor subcellular locations. Cancer
Lett. 318:124–134. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Andersen JB, Spee B, Blechacz BR, Avital
I, Komuta M, Barbour A, Conner EA, Gillen MC, Roskams T, Roberts
LR, et al: Genomic and genetic characterization of
cholangiocarcinoma identifies therapeutic targets for tyrosine
kinase inhibitors. Gastroenterology. 142:1021–1031.e15. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Brandi G, Farioli A, Astolfi A, Biasco G
and Tavolari S: Genetic heterogeneity in cholangiocarcinoma: A
major challenge for targeted therapies. Oncotarget. 6:14744–14753.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Roach A, Warner WA and Llanos AA: Building
capacity for human genetics and genomics research in Trinidad and
Tobago. Rev Panam Salud Publica. 38:425–430. 2015.PubMed/NCBI
|
